Skip to main content
logo
Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.5610
+0.0069 (1.25%)
At close: Sep 10, 2026, 4:00 PM EDT
0.5610
0.00 (0.00%)
After-hours: Sep 10, 2026, 4:04 PM EDT

Bone Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4.035.333.333.037.546.68
Cash & Short-Term Investments
4.035.333.333.037.546.68
Cash Growth
-39.28%60.42%9.87%-59.85%12.93%-
Other Receivables
0.010.01----
Receivables
0.010.01----
Prepaid Expenses
0.140.240.280.380.38-
Other Current Assets
0.260.210.260.330.58-
Total Current Assets
4.445.83.863.748.56.68
Total Assets
4.445.83.863.748.56.68

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.510.420.370.360.10.1
Other Current Liabilities
0000.472.44-
Total Current Liabilities
0.510.420.380.832.550.1
Total Liabilities
0.510.420.380.832.550.1

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000.01
Additional Paid-In Capital
93.5993.5188.583.8177.9177.04
Retained Earnings
-89.67-88.13-85.02-80.91-71.96-70.48
Shareholders' Equity
3.925.383.482.915.956.58
Total Liabilities & Equity
4.445.83.863.748.56.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
4.035.333.333.037.546.68
Net Cash Growth
-39.28%60.42%9.87%-59.85%12.93%-
Net Cash Per Share
2.244.5413.1469.01--
Filing Date Shares Outstanding
2.761.80.550.090.01-
Total Common Shares Outstanding
1.811.80.490.090.01-
Working Capital
3.925.383.482.915.956.58
Book Value Per Share
2.173.007.0832.64559.69-
Tangible Book Value
3.925.383.482.915.956.58
Tangible Book Value Per Share
2.173.007.0832.64559.69-
SEC Filings: 10-K · 10-Q